Counselors in Creswell, OR Accepting Medicare

5 Counselors found. Showing 1 - 5

Ms. Susan Lyn Johnson Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 83034 Scott Ln, Creswell, OR 97426 Phone: 541-895-4421

Megan Leatherman Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 30420 Camas Swale Rd, Creswell, OR 97426 Phone: 541-895-4892

Elena D Shore, LCSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 285 E Oregon Ave, Creswell, OR 97426 Phone: 541-870-1122

Brian Cantoran Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 640 Meadow Ln, Creswell, OR 97426 Phone: 541-954-7406

Karrie Lowry Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 33405 East Tate Rd, Creswell, OR 97426 Phone: 541-895-5418

News Archive

Break-induced Replication more likely to cause genetic mutation than normal cell repair

Researchers from Indiana University-Purdue University Indianapolis and Umea- University report in a study published in the February 15, 2011, issue of PLoS Biology that a method by which cells repair breaks in their DNA, known as Break-induced Replication, is up to 2,800 times more likely to cause genetic mutation than normal cell repair.

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Gilead Sciences, Inc. today announced that detailed results from four Phase 3 clinical trials (NEUTRINO, FISSION, POSITRON and FUSION) evaluating sofosbuvir, the company's investigational once-daily nucleotide NS5B inhibitor for the treatment of chronic hepatitis C virus infection, will be presented this week in oral sessions at the 48th Annual Meeting of the European Association for the Study of the Liver in Amsterdam, The Netherlands.

New program appears to be effective in reducing risk of lymphedema in breast cancer survivors

Viewed as one of the most unfortunate outcomes of breast cancer treatment, lymphedema is characterized by an accumulation of lymph fluid in the interstitial spaces of the affected limb, leading to chronic ipsilateral limb swelling causing psychosocial distress and physical challenges for patients.

Aduro receives $442,000 grant under QTDP program to support Listeria-based immunotherapy platform

Aduro BioTech announced today that it has been awarded two cash grants totaling approximately $442,000 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.

Study identifies genetic marker which could personalize treatment for Crohn's disease

The largest study ever to look at why an expensive and commonly used group of drugs fails some patients with Crohn's disease has identified a genetic marker which could individualize drug treatment.

Read more Medical News

› Verified 6 days ago